• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Four steps to safety oversight: DSMBs, CECs and medical monitors

Four steps to safety oversight: DSMBs, CECs and medical monitors

February 20, 2018 By Danielle Kirsh

imarcRachel Silver-Kessler, Director of Clinical Support Services, IMARC

Research sponsors and sites know the importance of implementing quality assurance processes for their clinical studies. For safety oversight, what steps can be followed to incorporate Quality Assurance into data safety monitoring boards, clinical events committees and medical monitoring? Take a look at these four tips:

1. Follow thoughtful procedures

The FDA guidance, The Establishment and Operation of Clinical Trial Data Monitoring Committees for Clinical Trial Sponsors recommends that data monitoring committees (DMCs) follow written procedures to guide its activities, including for composing safety groups and assessing potential conflicts of interest, holding meetings, and for the format of reports to the group.

2. Gain consensus and implement a charter

The FDA Guidance also encourages DMCs to operate under a written charter that identifies the procedures to be followed (see Step 1).  The charter will also outline roles and responsibilities of those in or interacting with the safety group, so collaboration and consensus from various stakeholders are important. The charter should also specify details for the study including scheduling of meetings, how a quorum will be defined, and how meeting minutes will be recorded and stored.

3. Maintain well-organized documentation

Speaking of meeting minutes, a safety oversight group should record the details of its activities and decisions. The charter will outline who is responsible for this, how issues should be communicated and how records will be retained during the study and archived after the study concludes. If an outsourced administrator is used to support safety oversight, maintaining this documentation should be a breeze, allowing the safety experts to focus on their study reviews.

4. Build quality control steps into processes

What better way to complement a focus on quality assurance than to add quality control into the picture? A DSMB, CEC or medical monitor has the ability to greatly impact a study through recommendations (such as to alter the protocol), adjudicated events or by providing other expert advice. Adding a QC step, such as a peer review, can ensure the accuracy of meeting minutes, consensus for adjudication decisions and consistent application of safety review criteria.

Following these four steps will bring quality assurance methods to your safety oversight groups for robust DSMBs, CECs and medical monitoring processes. For other best practices and qualities to look for from your safety administrator, download our guide.

What recommendations do you have for bringing quality into safety management for clinical studies?

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

Filed Under: Blog Tagged With: IMARC

More recent news

  • Carlsmed names chief product and AI officer as it claims CMS reimbursements
  • Integra LifeSciences says Cincinnati plant flooding will cost millions
  • Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe
  • Edwards earns FDA approval for first-of-its-kind size-adjustable pediatric heart valve
  • Leading medical device experts and MDO launch Medtech Innovation Board

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy